NASDAQ · Medical - Instruments & Supplies
NNNN (NNNN) Stock
$7.22
-1.10%
NASDAQ: NNNN
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Anbio Biotechnology Files Mixed Shelf Registration
MT Newswires · Jul 9, 2026
US Undiscovered Gems To Watch In May 2026
Simply Wall St. · May 29, 2026
Discover 3 Undiscovered Gems in the US Market
Simply Wall St. · May 29, 2026
Uncovering US Market's 3 Undiscovered Gems With Potential
Simply Wall St. · May 28, 2026
Discovering US Undiscovered Gems In May 2026
Simply Wall St. · May 21, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held4.78%
Institutions Held4.90%
Institutions Float Held5.15%
Peer Comparison
About NNNN
NNNN is led by CEO Michael Lau, employs 27 people, headquartered in DE, publicly traded since 2025.
NNNN stock trades at $7.22 with a market capitalization of $316.89M. The stock is valued at a price-to-earnings (P/E) ratio of 37.75, price-to-book of 10.63, price-to-sales of 27.21. Over the past 52 weeks the stock has ranged between $6.61 and $51.33, and currently trades 85.9% below its 52-week high.
On profitability, NNNN generates a return on equity (ROE) of 27.49% — well above the market average, a sign of a high-quality business, return on capital employed of 25.46%, an operating margin of 66.47%, a net profit margin of 72.09%.